Reporting on invasive lobular breast cancer in clinical trials: a systematic review
Abstract Invasive lobular breast cancer (ILC) differs from invasive breast cancer of no special type in many ways. Evidence on treatment efficacy for ILC is, however, lacking. We studied the degree of documentation and representation of ILC in phase III/IV clinical trials for novel breast cancer tre...
Main Authors: | Karen Van Baelen, Josephine Van Cauwenberge, Marion Maetens, Gabriela Beck, Ann Camden, Megan-Claire Chase, Valerie Fraser, Siobhan Freeney, Laurie Hutcheson, Julia K. Levine, Tone Lien, Rian Terveer, Claire Turner, Elzbieta Senkus, Rachel C. Jankowitz, Vincent Vandecaveye, Giuseppe Floris, Patrick Neven, Hans Wildiers, Elinor Sawyer, Anne Vincent-Salomon, Patrick W. B. Derksen, Christine Desmedt |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-024-00627-5 |
Similar Items
-
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology
by: Gitte Zels, et al.
Published: (2024-06-01) -
International survey on invasive lobular breast cancer identifies priority research questions
by: Steffi Oesterreich, et al.
Published: (2024-07-01) -
Reporting on patient’s body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review
by: Josephine Van Cauwenberge, et al.
Published: (2024-05-01) -
Adipocyte heterogeneity and tumor infiltration of adipose tissue in patients with metastatic breast cancer
by: Hava Izci, et al.
Published: (2025-02-01) -
Timing evolution of lobular breast cancer through phylogenetic analysis
by: Danai Fimereli, et al.
Published: (2022-08-01)